These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 10665619)

  • 1. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication.
    Sensky T; Turkington D; Kingdon D; Scott JL; Scott J; Siddle R; O'Carroll M; Barnes TR
    Arch Gen Psychiatry; 2000 Feb; 57(2):165-72. PubMed ID: 10665619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up.
    Turkington D; Sensky T; Scott J; Barnes TR; Nur U; Siddle R; Hammond K; Samarasekara N; Kingdon D
    Schizophr Res; 2008 Jan; 98(1-3):1-7. PubMed ID: 17936590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behaviour therapy in patients with schizophrenia who are not prescribed antipsychotic medication: a case series.
    Christodoulides T; Dudley R; Brown S; Turkington D; Beck AT
    Psychol Psychother; 2008 Jun; 81(Pt 2):199-207. PubMed ID: 18230197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.
    Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D
    JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia.
    Velligan DI; Bow-Thomas CC; Huntzinger C; Ritch J; Ledbetter N; Prihoda TJ; Miller AL
    Am J Psychiatry; 2000 Aug; 157(8):1317-23. PubMed ID: 10910797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project.
    Jackson HJ; McGorry PD; Killackey E; Bendall S; Allott K; Dudgeon P; Gleeson J; Johnson T; Harrigan S
    Psychol Med; 2008 May; 38(5):725-35. PubMed ID: 18005494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Befriending patients with medication-resistant schizophrenia: can psychotic symptoms predict treatment response?
    Samarasekera N; Kingdon D; Siddle R; O'Carroll M; Scott JL; Sensky T; Barnes TR; Turkington D
    Psychol Psychother; 2007 Mar; 80(Pt 1):97-106. PubMed ID: 17346383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial.
    Valmaggia LR; van der Gaag M; Tarrier N; Pijnenborg M; Slooff CJ
    Br J Psychiatry; 2005 Apr; 186():324-30. PubMed ID: 15802690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cognitive behavioral therapy for insomnia in schizophrenia patients with sleep Disturbance: A non-randomized, assessor-blind trial.
    Hwang DK; Nam M; Lee YG
    Psychiatry Res; 2019 Apr; 274():182-188. PubMed ID: 30807969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study.
    Favrod J; Rexhaj S; Bardy S; Ferrari P; Hayoz C; Moritz S; Conus P; Bonsack C
    Eur Psychiatry; 2014 Jun; 29(5):275-81. PubMed ID: 24176646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome in brief cognitive behavior therapy for schizophrenia.
    Brabban A; Tai S; Turkington D
    Schizophr Bull; 2009 Sep; 35(5):859-64. PubMed ID: 19571248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive-behavioral therapy for medication-resistant symptoms.
    Garety PA; Fowler D; Kuipers E
    Schizophr Bull; 2000; 26(1):73-86. PubMed ID: 10755670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive behavioral therapy for schizophrenia: an empirical review.
    Rector NA; Beck AT
    J Nerv Ment Dis; 2001 May; 189(5):278-87. PubMed ID: 11379970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary controlled trial of cognitive behavioral therapy in clozapine-resistant schizophrenia.
    Barretto EM; Kayo M; Avrichir BS; Sa AR; Camargo Md; Napolitano IC; Nery FG; Pinto JA; Bannwart S; Scemes S; Di Sarno E; Elkis H
    J Nerv Ment Dis; 2009 Nov; 197(11):865-8. PubMed ID: 19996727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up.
    Durham RC; Guthrie M; Morton RV; Reid DA; Treliving LR; Fowler D; Macdonald RR
    Br J Psychiatry; 2003 Apr; 182():303-11. PubMed ID: 12668405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
    Favrod J; Nguyen A; Chaix J; Pellet J; Frobert L; Fankhauser C; Ismailaj A; Brana A; Tamic G; Suter C; Rexhaj S; Golay P; Bonsack C
    Psychother Psychosom; 2019; 88(2):84-95. PubMed ID: 30783071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial.
    Morrison AP; Hutton P; Wardle M; Spencer H; Barratt S; Brabban A; Callcott P; Christodoulides T; Dudley R; French P; Lumley V; Tai SJ; Turkington D
    Psychol Med; 2012 May; 42(5):1049-56. PubMed ID: 21914252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.